{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:51:04Z","timestamp":1783529464690,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114381","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T16:36:06Z","timestamp":1741451766000},"page":"114381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comprehensive pan-cancer single-cell analysis reveals glycolysis-related signatures as predictive biomarkers for immunotherapy response and their role in bladder cancer"],"prefix":"10.1016","volume":"152","author":[{"given":"Yingjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2025.114381_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051119","article-title":"Warburg and beyond: the power of mitochondrial metabolism to collaborate or replace fermentative glycolysis in Cancer","volume":"12","author":"Cassim","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2025.114381_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.gendis.2019.10.007","article-title":"Metabolic reprogramming in tumors: contributions of the tumor microenvironment","volume":"7","author":"Lane","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.intimp.2025.114381_bb0015","doi-asserted-by":"crossref","first-page":"217156","DOI":"10.1016\/j.canlet.2024.217156","article-title":"Glycolysis, the sweet appetite of the tumour microenvironment","volume":"600","author":"Kooshan","year":"2024","journal-title":"Cancer Lett."},{"issue":"23","key":"10.1016\/j.intimp.2025.114381_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235912","article-title":"Targeting metabolism to control immune responses in Cancer and improve checkpoint blockade immunotherapy","volume":"13","author":"Luby","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","article-title":"Molecular and histopathology directed therapy for advanced bladder cancer","volume":"16","author":"Alifrangis","year":"2019","journal-title":"Nat. Rev. Urol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114381_bb0030","first-page":"2196","article-title":"Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models","volume":"18","author":"Kawahara","year":"2024","journal-title":"Mol. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114381_bb0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2025.114381_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1353787","article-title":"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114381_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ebiom.2019.01.036","article-title":"Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation","volume":"40","author":"Lee","year":"2019","journal-title":"EBioMedicine"},{"issue":"13","key":"10.1016\/j.intimp.2025.114381_bb0050","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1089\/ars.2019.7942","article-title":"Interweaving tumor heterogeneity into the cancer epigenetic\/metabolic axis","volume":"33","author":"Leung","year":"2020","journal-title":"Antioxid. Redox Signal."},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0055","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","article-title":"Best practices for single-cell analysis across modalities","volume":"24","author":"Heumos","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.intimp.2025.114381_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.omto.2021.04.001","article-title":"Single-cell RNA sequencing in cancer: applications, advances, and emerging challenges","volume":"21","author":"Sun","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"7","key":"10.1016\/j.intimp.2025.114381_bb0065","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s12033-023-00777-0","article-title":"Single-cell RNA sequencing: technological progress and biomedical application in cancer research","volume":"66","author":"Chang","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.intimp.2025.114381_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102021","article-title":"Integration RNA bulk and single cell RNA sequencing to explore the change of glycolysis-related immune microenvironment and construct prognostic signature in head and neck squamous cell carcinoma","volume":"46","author":"Nie","year":"2024","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114381_bb0075","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0080","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat. Med."},{"issue":"D1","key":"10.1016\/j.intimp.2025.114381_bb0085","doi-asserted-by":"crossref","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","article-title":"TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment","volume":"49","author":"Sun","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.114381_bb0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"269","key":"10.1016\/j.intimp.2025.114381_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.intimp.2025.114381_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.intimp.2025.114381_bb0105","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","article-title":"Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114381_bb0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.intimp.2025.114381_bb0115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with Nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"issue":"7693","key":"10.1016\/j.intimp.2025.114381_bb0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2025.114381_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002309","article-title":"Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis","volume":"14","author":"Snyder","year":"2017","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.114381_bb0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41591-019-0349-y","article-title":"Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma","volume":"25","author":"Zhao","year":"2019","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.114381_bb0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","article-title":"Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma","volume":"26","author":"Braun","year":"2020","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.intimp.2025.114381_bb0140","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0145","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"26","key":"10.1016\/j.intimp.2025.114381_bb0150","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114381_bb0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) Myofibroblasts as a determinant of patient response to Cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.intimp.2025.114381_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa345","article-title":"Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer","volume":"22","author":"Ju","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114381_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2025.114381_bb0170","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2018.03.026","article-title":"Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade","volume":"173","author":"Shukla","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.114381_bb0175","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1038\/s41467-020-18546-x","article-title":"A gene expression signature of TREM2(hi) macrophages and \u03b3\u03b4 T cells predicts immunotherapy response","volume":"11","author":"Xiong","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.114381_bb0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41525-021-00169-w","article-title":"Ratio of the interferon-\u03b3 signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma","volume":"6","author":"Cui","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.intimp.2025.114381_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.758288","article-title":"Single-cell transcriptomic analysis reveals a tumor-reactive T cell signature associated with clinical outcome and immunotherapy response in melanoma","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114381_bb0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: computational identification of cell doublets in single-cell transcriptomic data","volume":"8","author":"Wolock","year":"2019","journal-title":"Cell Syst."},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0195","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/s41401-024-01264-1","article-title":"Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy","volume":"45","author":"Ni","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.114381_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2025.114381_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13062-024-00478-x","article-title":"CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1\u03b1-mediated glycometabolism alteration","volume":"19","author":"Geng","year":"2024","journal-title":"Biol. Direct"},{"issue":"9\u201310","key":"10.1016\/j.intimp.2025.114381_bb0210","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s10495-024-01952-7","article-title":"Metabolic heterogeneity and potential immunotherapeutic responses revealed by single-cell transcriptomics of breast Cancer","volume":"29","author":"Tang","year":"2024","journal-title":"Apoptosis."},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0215","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1097\/JS9.0000000000001479","article-title":"Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study","volume":"110","author":"Guo","year":"2024","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.intimp.2025.114381_bb0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12916-021-01925-6","article-title":"Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment","volume":"19","author":"Ho","year":"2021","journal-title":"BMC Med."},{"issue":"13","key":"10.1016\/j.intimp.2025.114381_bb0225","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41388-023-02613-w","article-title":"The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.intimp.2025.114381_bb0230","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s12094-021-02630-9","article-title":"COPB2: a transport protein with multifaceted roles in cancer development and progression","volume":"23","author":"Feng","year":"2021","journal-title":"Clin. Transl. Oncol."},{"issue":"16","key":"10.1016\/j.intimp.2025.114381_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169341","article-title":"Cyclophilin a\/CD147 interaction: a promising target for anticancer therapy","volume":"23","author":"Han","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114381_bb0240","article-title":"Alternative adenosine receptor activation: the netrin-Adora2b link","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114381_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060615","article-title":"ERBB2 regulates MED24 during cancer progression in mice with Pten and Smad4 deletion in the pulmonary epithelium","volume":"8","author":"Liu","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0250","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/MCB.05245-11","article-title":"Mediator subunits MED1 and MED24 cooperatively contribute to pubertal mammary gland development and growth of breast carcinoma cells","volume":"32","author":"Hasegawa","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0255","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.7150\/thno.81760","article-title":"Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics","volume":"13","author":"\u010caval","year":"2023","journal-title":"Theranostics"},{"issue":"16","key":"10.1016\/j.intimp.2025.114381_bb0260","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/jcmm.17832","article-title":"PSMC4 promotes prostate carcinoma progression by regulating the CBX3-EGFR-PI3K-AKT-mTOR pathway","volume":"27","author":"Liu","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.114381_bb0265","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.intimp.2025.114381_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1555","article-title":"Snai2-mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB","volume":"14","author":"Jiang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2025.114381_bb0275","article-title":"Upregulation of COPB2 promotes prostate Cancer proliferation and invasion through the MAPK\/TGF-\u03b2 signaling pathway","volume":"12","author":"Feng","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114381_bb0280","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12079-022-00671-5","article-title":"Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2\/PI3K\/AKT axis in an ETS1-dependent manner","volume":"16","author":"Mi","year":"2022","journal-title":"J. Cell Commun. Signal."},{"issue":"8","key":"10.1016\/j.intimp.2025.114381_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14082038","article-title":"Implication of COPB2 expression on cutaneous squamous cell carcinoma pathogenesis","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2025.114381_bb0290","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3892\/etm.2021.10224","article-title":"Silencing the COPB2 gene decreases the proliferation, migration and invasion of human triple-negative breast cancer cells","volume":"22","author":"Wu","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114381_bb0295","doi-asserted-by":"crossref","first-page":"902","DOI":"10.18632\/aging.102663","article-title":"SAG expression associates with COPB2-related signaling and a poorer prognosis in breast cancer","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.intimp.2025.114381_bb0300","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.biopha.2018.04.006","article-title":"COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells","volume":"103","author":"Pu","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2025.114381_bb0305","first-page":"1195","article-title":"Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway","volume":"54","author":"An","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114381_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240106","article-title":"COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK\/c-Jun signaling pathway","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS ONE"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925003716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925003716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:07:35Z","timestamp":1757912855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925003716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":62,"alternative-id":["S1567576925003716"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114381","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive pan-cancer single-cell analysis reveals glycolysis-related signatures as predictive biomarkers for immunotherapy response and their role in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114381"}}